Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks

✍ Scribed by Nobuyuki Yamamoto; Masahiro Andoh; Masaaki Kawahara; Masahiro Fukuoka; Hisanobu Niitani

• Book ID: 108586359
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 140 KB
• Volume: 100
• Category: Article
• ISSN: 1347-9032
• DOI: 10.1111/j.1349-7006.2008.01023.x